Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiqipeiyuan prescription
- Development stage
- Unknown
- Lead developer
- Renji Hospital
- Administration
- Oral
01
Overview
Yiqipeiyuan prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by Renji Hospital at the Shanghai Jiaotong University School of Medicine. It is primarily indicated for the treatment of acute kidney injury (AKI), specifically targeting patients presenting with "qi deficiency syndrome" according to TCM diagnostic criteria. The prescription is designed to supplement Qi and strengthen the body's "Yuan Qi" (original energy) to facilitate renal repair and improve clinical outcomes. It is currently being investigated in prospective, randomized, double-blind, controlled clinical trials to evaluate its efficacy and safety as part of an integrated Chinese and Western medicine protocol for AKI management.
- Other names
- Yiqipeiyuan formulaYiqipeiyuan decoction
02
Targets
SIRT1 (NAD-dependent protein deacetylase sirtuin-1)PPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)
Beyond the preview
Go deeper on yiqipeiyuan prescription.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiqipeiyuan prescription.